In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Cardio-Oncology in 2019 - The new frontier
Session

Congress : Heart Failure 2019 - 6th World Congress on Acute Heart Failure

Topic : Cardio-Oncology

  • Session type : Symposium
  • Date : 27 May 2019
  • Time : 08:30 - 10:00
  • Joint Session with ESC Council of Cardio-Oncology

4 presentations in this session

Cardio-Oncology - Where have we come from in the last 20 years?

Congress : Heart Failure 2019

  • Session : Cardio-Oncology in 2019 - The new frontier
  • Speaker : P Van Der Meer (Groningen,NL)
  • Joint Session with ESC Council of Cardio-Oncology

How do we deliver Cardio-Oncology services in 2019?

Congress : Heart Failure 2019

  • Session : Cardio-Oncology in 2019 - The new frontier
  • Speaker : T Lopez Fernandez (Madrid,ES)
  • Joint Session with ESC Council of Cardio-Oncology

Can we prevent heart failure in cancer patients?

Congress : Heart Failure 2019

  • Session : Cardio-Oncology in 2019 - The new frontier
  • Speaker : R Pudil (Hradec Kralove,CZ)
  • Joint Session with ESC Council of Cardio-Oncology

How should cancer survivors be followed up after cancer treatment?

Congress : Heart Failure 2019

  • Session : Cardio-Oncology in 2019 - The new frontier
  • Speaker : DT Farmakis (Athens,GR)
  • Joint Session with ESC Council of Cardio-Oncology

Members get more

Join now
  • 1ESC Professional Members – access all resources from ESC Congress and ESC Asia with APSC & AFC
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s congress resources
  • 3Under 40 or in training - with a Combined Membership, access resources from all congresses
Join now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are